The chlamydia screening studies: rationale and design

被引:40
|
作者
Low, N
McCarthy, A
Macleod, J
Salisbury, C
Horner, PJ
Roberts, TE
Campbell, R
Herring, A
Skidmore, S
Sanford, E
Sterne, JAC
Smith, GD
Graham, A
Huengsberg, M
Ross, J
Egger, M
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
[2] Univ Birmingham, Dept Primary Care, Birmingham B15 2TT, W Midlands, England
[3] Univ Bristol, Bristol BS6 6JL, Avon, England
[4] United Bristol Healthcare Trust, Milne Ctr, Bristol BS2 8HW, Avon, England
[5] Publ Hlth Lab Serv, Bristol Lab, Bristol BS2 8EL, Avon, England
[6] Publ Hlth Lab Serv, Birmingham Lab, Birmingham B9 5ST, W Midlands, England
[7] Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England
[8] Heart Birmingham Primary Care Trust, Whittall St Clin, Birmingham B4 6DH, W Midlands, England
关键词
D O I
10.1136/sti.2003.006197
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Screening has been recommended to reduce the prevalence and morbidity associated with genital chlamydia infection in the United Kingdom. Methods: We describe the rationale and study design of the Chlamydia Screening Studies (ClaSS), a collaborative project designed to evaluate screening outside genitourinary medicine clinics. A nonselective, active screening approach in 16-39 year olds randomly sampled from 27 general practice lists in the Bristol and Birmingham areas formed the basis of interlinked studies: a case-control study was used to investigate factors to improve the targeting of screening; participants with chlamydia were invited to enrol in a randomised controlled trial to evaluate partner notification conducted in primary care; and laboratory based studies were used to assess the best specimens and tests. We also explored psychosocial effects of screening and partner notification and modelled the cost effectiveness of the programme. Conclusion: Results from four pilot practices show that mailing of specimens for chlamydia testing is feasible but that it is difficult to achieve high response rates with postal screening. The high prevalence of asymptomatic infection in men suggests that efforts to screen men for chlamydia should be strengthened.
引用
收藏
页码:342 / 348
页数:7
相关论文
共 50 条
  • [31] Opportunistic screening for chlamydia
    Banerjee, I
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2005, 31 (01): : 81 - 81
  • [32] Chlamydia screening in triage
    Mudiwa, V
    Curran, B
    Jungmann, E
    SEXUALLY TRANSMITTED INFECTIONS, 2006, 82 : A12 - A12
  • [33] The PRImary care Screening Methods (PRISM) study: Rationale and design considerations
    Bryan, Craig J.
    Allen, Michael H.
    Thomsen, Cynthia J.
    May, Alexis M.
    Baker, Justin C.
    Harris, Julia A.
    Bryan, AnnaBelle O.
    Russell, William A.
    CONTEMPORARY CLINICAL TRIALS, 2019, 84
  • [34] Rationale and Design of the Australasian Registry of Screening ECGs in National Athletes Project
    Orchard, Jessica J.
    La Gerche, Andre
    Puranik, Rajesh
    Raju, Hariharan
    Davis, Angus J.
    Eggleton, Simon
    Driscoll, Tim
    Lorimer, Michelle
    Doughty, Robert N.
    Hamilton, Bruce
    Drezner, Jonathan A.
    Orchard, John W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (16):
  • [35] GPU-accelerated virtual screening: Rationale, challenges, and case studies
    Isayev, Olexandr
    Fourches, Denis
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [36] Redesigning the rationale for design rationale
    Atwood, Michael E.
    Horner, John
    HUMAN-COMPUTER INTERACTION, PT 1, PROCEEDINGS: INTERACTION DESIGN AND USABILITY, 2007, 4550 : 11 - +
  • [37] Opportunistic screening for Chlamydia -: Microbiological input is essential in Chlamydia screening programmes -: Reply
    Moens, V
    Baruch, G
    BRITISH MEDICAL JOURNAL, 2003, 327 (7409): : 290 - 290
  • [38] Screening CT: Rationale
    Brant-Zawadzki, MN
    RADIOGRAPHICS, 2002, 22 (06) : 1532 - 1536
  • [39] University undergraduates' knowledge of chlamydia screening services and chlamydia infection following the introduction of a National Chlamydia Screening Programme
    Greaves, Anna
    Lonsdale, Samantha
    Whinney, Stephanie
    Hood, Elizabeth
    Mossop, Hilary
    Olowokure, Babatunde
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2009, 14 (01): : 61 - 68
  • [40] Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies
    Lo Re, Vincent, III
    Haynes, Kevin
    Ming, Eileen E.
    Ives, Jennifer Wood
    Horne, Laura N.
    Fortier, Kimberly
    Carbonari, Dena M.
    Hennessy, Sean
    Cardillo, Serena
    Reese, Peter P.
    Reddy, K. Rajender
    Margolis, David
    Apter, Andrea
    Kimmel, Stephen E.
    Roy, Jason
    Freeman, Cristin P.
    Razzaghi, Hanieh
    Holick, Crystal N.
    Esposito, Daina B.
    Van Staa, Tjeerd-Pieter
    Bhullar, Harshvinder
    Strom, Brian L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (11) : 1202 - 1215